StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities research analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALAGet Free Report) in a research note issued on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA opened at $0.01 on Thursday. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12. The business has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

See Also

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.